Cargando…
White matter changes in Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD). It is characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) and the formation of Lewy bodies (LBs). Although PD is primarily considered a gra...
Autores principales: | Yang, Kai, Wu, Zhengqi, Long, Jie, Li, Wenxin, Wang, Xi, Hu, Ning, Zhao, Xinyue, Sun, Taolei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618166/ https://www.ncbi.nlm.nih.gov/pubmed/37907554 http://dx.doi.org/10.1038/s41531-023-00592-z |
Ejemplares similares
-
The emerging roles of piezo1 channels in animal models of multiple sclerosis
por: Yang, Kai, et al.
Publicado: (2022) -
The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease
por: Liu, Hailing, et al.
Publicado: (2021) -
Outer Retinal Layer Thickness Changes in White Matter Hyperintensity and Parkinson's Disease
por: Zhao, Yitian, et al.
Publicado: (2021) -
The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson’s Disease (PD) and Major Depressive Disorder (MDD)
por: Yang, Kai, et al.
Publicado: (2019) -
White-Matter Changes Correlate with Cognitive Functioning in Parkinson’s Disease
por: Theilmann, Rebecca J., et al.
Publicado: (2013)